Cancer patients who had higher levels of 25-Hydroxyvitamin D were linked with better survival rates and longer remission than those who are vitamin D-deficient.
The findings were published in July 2014 in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The meta-analysis reviewed 25 studies that measured vitamin D levels at or near the time of diagnosis in 17,332 cancer patients. The authors found that patients with higher vitamin D levels were linked with better outcomes in a several cancer types.
[…]
Read the full article here
Written by Dr. Alex Rinehart